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	 One‐pot	 condensation	 of	malononitrile	 (1),	 4‐methylpentan‐2‐one	 (2),	 aryl	 carboxaldehyde
(3a‐f)	 and	 ammonium	 acetate	 in	 ethanol	 afforded	 2‐amino‐5‐isopropyl‐4‐(4‐aryl)‐6‐
methylnicotinonitriles	(4a‐f).	The	antioxidant	activity	of	the	new	synthesized	compounds	was
evaluated	and	the	result	showed	all	compound	exhibited	weak	anti‐oxidant	activities.	
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1.	Introduction	
	
Multicomponent	 coupling	 reactions	 (MCRs)	 have	 been	
frequently	 used	 by	 synthetic	 chemists	 as	 a	 facile	 means	 to	
generate	molecular	diversity	from	bifunctional	substrates	that	
react	sequentially	in	an	intermolecular	 fashion	[1,2].	Devising	
such	 types	 of	 MCRs	 that	 achieve	 the	 formation	 of	 multiple	
bonds	 in	 a	 single	 operation	 is	 one	of	 the	major	 challenges	 in	
modern	organic	synthesis	[3,4].	As	such	processes	avoid	time	
consuming	 and	 costly	 purification	 processes,	 as	 well	 as	
protection‐deprotection	 steps,	 they	 are	 inherently	 more	
environmentally	benign	and	atom	economic	[5].	
Many	naturally	occurring	as	well	as	synthetic	compounds	
containing	 the	 pyridine	 scaffold	 exhibit	 interesting	 pharma‐
cological	properties	[6‐10].	Furthermore,	pyridine	is	one	of	the	
most	popular	N‐heteroaromatics	 incorporated	 into	 the	 struc‐
ture	 of	 many	 pharmaceuticals.	 Among	 these,	 cyanopyridines	
with	 different	 alkyl	 and	 aryl	 groups	 were	 found	 to	 have	
antihypertensive	 [11],	 anti‐inflammatory,	 analgesic,	 anti‐
pyretic	 properties	 [12,13]	 as	 well	 as	 1KK‐b	 inhibitor	 pro‐
perties	[14].	
Reactive	oxygen	species	(ROS),	including	free	radicals,	led	
to	 a	 decrease	 in	 the	 antioxidant	 capacity	 and	 may	 generate	
other	 reactive	 species	 that	 damage	 the	 living	 cell.	 Oxidative	
stress	 may	 arise	 in	 a	 biological	 system	 after	 increasing	
exposure	to	oxidants,	so	the	antioxidants	play	a	major	role	in	
the	protection	of	biological	 systems	against	 threats.	Different	
types	 of	 antioxidants	 such	 as	 Vitamins	 C	 and	 E,	 glutathione,	
lipoic	acid	and	butylated	phenols	were	widely	used	in	different	
fields	 of	 industry	 and	 medicine	 to	 interrupt	 radical‐chain	
oxidation	processes	 that	attract	a	high	scientific	 interest	 [15‐
17].	We	reported	herein,	the	one	pot	multicomponent	coupling	
synthesis	of	some	2‐aminopyridines	in	order	to	evaluate	their	
antioxidant	activities.		
	
2.	Experimental	
	
2.1.	Instrumentation	
	
All	melting	points	are	determined	on	Gallenkamp	electric	
melting	 point	 apparatus	 (uncorrected).	 Thin	 layer	 chroma‐
tography	 (TLC)	 analysis	 was	 carried	 out	 on	 silica	 gel	 60F254	
precoated	 aluminum	 sheets.	 The	 IR	 spectra	 were	 recorded	
(KBr)	 on	 a	 on	 a	 Nicolet	 i55	 FT‐IR	 Spectrophotometer	 at	 the	
Microanalytical	Unit,	Faculty	of	Science	and	Arts,	Ulla,	Taibah	
University,	Kingdom	of	Saudi	Arabia.	 1H	and	13C	NMR	spectra	
were	 recorded	at	 600	and	150	MHz,	respectively,	on	a	 JEOL	
Spectrophotometer	using	CDCl3/DMSO‐d6	as	solvent	and	TMS		
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a, R = H; b, R = CH3; c, R = OCH3; d, R = 4-Cl; e, X = O; f, X= S 
	
Scheme	1
	
	
as	an	internal	reference,	King	Abdulaziz	University,	Faculty	of	
Science,	Kingdom	of	Saudi	Arabia.	The	mass	spectra	(EI)	were	
recorded	on	JEOL‐JMS	600	at	Assiut	University,	Assiut,	Egypt.	
Elemental	analyses	(C,	H	and	N)	were	carried	out	at	the	Micro	
analytical	 Center,	 Cairo	 University,	 Giza,	 Egypt.	 Biological	
activities	were	carried	at	Pharmacognosy	Department,	Faculty	
of	Pharmacy,	Mansoura	University,	Mansoura,	Egypt.	
	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	2‐amino‐5‐isopropyl‐6‐methyl‐4‐aryl	
nicotinonitriles	(4a‐f)	
	
General	 procedure:	 	 A	 mixture	 of	 aromatic	 aldehyde	 (20	
mmol),	 4‐methylpentan‐2‐one	 (1	 g,	 20	 mmol),	 malononitrile	
(1.32	g,	20	mmol)	and	ammonium	acetate	(18.64	g,	160	mmol)	
in	ethyl	alcohol	(30	mL)	was	heated	under	reflux	for	24	h.	The	
reaction	mixture	was	 cooled	 and	 the	 formed	precipitate	was	
filtered,	 washed	 with	 water,	 dried	 and	 crystallized	 from	
methanol	to	give	compound	4a‐f	(Scheme	1,	Figure	1).	
2‐Amino‐5‐isopropyl‐6‐methyl‐4‐phenylnicotinonitrile	 (4a):	
Color:	White	crystals.	Yield:	73%.	M.p.:	178‐179	°C.	FT‐IR	(KBr,	
ν,	 cm‐1):	 3426,	 3316	 (NH2),	 2208	 (CN),	 1650	 (C=N).	 1H	NMR	
(600	MHz,	 DMSO‐d6,	 δ,	 ppm):	 0.94	 (d,	 6H,	 J	 =	 6.6	 Hz,	 2CH3),	
2.10	(s,	1H,	J	=	6.6	Hz,	CH),	2.52	(s,	3H,	CH3),	5.88	(br,	2H,	NH2),	
7.48‐7.57	(m,	5H,	Ar‐H).	13C	NMR	(150	MHz,	DMSO‐d6,	δ,	ppm):	
165.3	(C6),	160.5	(C2),	153.3	(C4),	136.9	(C1'),	129.4	(C4'),	128.6	
(2C,	 C3',	 C5'),	 128.1	 (2C,	 C2',	 C6'),	 117.3	 (C5),	 113.4	 (CN),	 86.4	
(C3),	47.5	 (C7),	28.6	 (C8),	22.4	 (2C,	C9,	 C10).	MS	 (EI,	m/z	 (%)):	
251.39	(M+,	9.2),	236	(41.8),	210	(27.5),	209	(100),	164	(11.3),	
89	 (17.6),	 77	 (63.3),	 51	 (15.6).	 Anal.	 calcd.	 for	 C16H17N3:	 C,	
76.46;	H,	6.82;	N,	16.72.	Found:	C,	76.40;	H,	6.85;	N,	16.67%.	
2‐Amino‐5‐isopropyl‐6‐methyl‐4‐p‐tolylnicotinonitrile	 (4b):	
Color:	 Yellow	 crystals.	 Yield:	 74%.	 M.p.:	 194‐196	 °C.	 FT‐IR	
(KBr,	 ν,	 cm‐1):	 3411,	 3320	 (NH2),	 2211	 (CN),	 1651	 (C=N).	 1H	
NMR	(600	MHz,	CDCl3,	δ,	ppm):	0.95	(d,	6H,	J	=	6.6	Hz,	2CH3),	
2.09	(septet,	1H,	J	=	6.6	Hz,	CH),	2.42	(s,	3H,	CH3Ar)	2.53(s,	3H,	
CH3),	 5.32	 (br,	 2H,	NH2),	 7.30	 (dd,	 2H,	 J	 =	 7.2	Hz,	 Ar‐H)	 7.48	
(dd,	2H,	J	=	7.2	Hz,	Ar‐H).	13C	NMR	(150	MHz,	CDCl3,	δ,	ppm):	
165.4	(C6),	160.2	(C2),	154.2	(C4),	139.9	(C4'),	133.9	(C1'),	129.5	
(2C,	 C3',	 C5'),	 128.1	 (2C,	 C2',	 C6'),	 117.3	 (C5),	 114.1	 (CN),	 87.1	
(C3),	 47.8	 (C7),	 28.8	 (C8),	 22.5	 (2C,	 C9,	 C10),	 21.4	 (CH3Ar).	MS	
(EI,	m/z	 (%)):	 264.3	 (M+	 ‐1,	 0.1),	 250	 (10.8),	 223	 (100),	 210	
(2.5),	193	(4.2),	166	(5.2),	140	(16.0),	115	(30.7),	91	(28.8),	77	
(13.9),	65	(32.4),	51	(24.9).	Anal.	calcd.	for	C17H19N3:	C,	76.95;	
H,	7.22;	N,	15.84.	Found:	C,	76.91;	H,	7.18;	N,	15.78%.	
2‐Amino‐5‐isopropyl‐4‐(4‐methoxyphenyl)‐6‐methylnicotino	
nitrile	(4c):	Color:	Pale	yellow	crystals.	Yield:	80%.	M.p.:	171‐
173	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3405,	 3315	 (NH2),	 2212	 (CN),	
1648	(C=N).	1H	NMR	(600	MHz,	CDCl3,	δ,	ppm):	0.95	(d,	6H,	J	=	
6.6	 Hz,	 2CH3),	 2.09	 (septet,	 1H,	 J	 =	 6.6	 Hz,	 CH),	 2.51	 (s,	 3H,	
CH3),	3.87	(s,	3H,	OCH3Ar),	5.	28	(br,	2H,	NH2),	7.01	(dd	2H,	J	=	
9.0	 Hz,	 Ar‐H),	 7.55	 (dd	 2H,	 J	 =	 9.0	 Hz,	 Ar‐H).	 13C	 NMR	 (150	
MHz,	CDCl3,	δ,	ppm):	163.3	(C6),	160.8	 (C4'),	160.2	 (C2),	153.8	
(C4),	 129.6	 (2C,	C2',	 C6'),	 129.0	 (C1')	117.6	 (C5),	 114.3	 (2C,	C3',	
C5'),	113.9	(CN),	86.9	(C3),	55.4	(OCH3Ar),	47.8	(C7),	28.8	(C8),	
22.5	(2C,	C9,	C10)	163.3	(C6),	160.8	(C4'),	160.2	(C2),	153.8(C4),	
129.6	 (2C,	 C2',	 C6'),	 129.0	 (C1')	 117.6	 (C5),	 114.3	 (2C,	 C3',	 C5'),	
113.9	(CN),	86.9	(C3),	55.4	(OCH3Ar),	47.8	(C7),	28.8	(C8),	22.5	
(2C,	C9,	C10).	MS	(EI,	m/z	(%)):	263	(M+	‐NH3,	11.7),	240	(20.1),	
239	 (100),	224	 (9.5),	 196	 (10.1),	 142	 (10.9),	 114	 (22.9),	 103	
(17.2),	 77	 (23.6),	 63	 (41.3),	 51	 (32.4).	 Anal.	 calcd.	 for	
C17H19N3O:	C,	72.57;	H,	6.81;	N,	14.94.	Found:	C,	72.51;	H,	6.85;	
N,	14.90%.	
2‐Amino‐5‐isopropyl‐4‐(4‐chlorophenyl)‐6‐methylnicotino	
nitrile	(4d):	Color:	Pale	yellow	crystals.	Yield:	70%.	M.p.:	210‐
212	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3416,	 3316	 (NH2),	 2212	 (CN),	
1650	(C=N).	1H	NMR	(600	MHz,	DMSO‐d6,	δ,	ppm):	0.94	(d,	6H,	
J	=	6.6	Hz,	2CH3),	2.10	(septet,	1H,	 J	=	6.6	Hz,	CH),	2.51(s,	3H,	
CH3),	 6.17	 (br,	 2H,	NH2),	7.48	 (dd,	2H,	 J	 =	 8.4	Hz,	Ar‐H),	7.53	
(dd,	 2H,	 J	 =	 8.4	 Hz,	 Ar‐H).	 13C	 NMR	 (150	 MHz,	 DMSO‐d6,	 δ,	
ppm):	165.4	(C6),	160.7	(C2),	152.5	(C4),	135.5	(C1'),	135.1	(C4'),	
129.6	 (2C,	 C3',	 C5')	 128.7	 (2C,	 C2',	 C6'),	 117.0	 (C5),	 112.8	 (CN),	
85.9	 (C3),	 47.4	 (C7),	 28.5	 (C8),	 22.4	 (2C,	 C9,	 C10).	MS	 (EI,	m/z	
(%)):	 270	 (M+‐CH3,	 11.7),	 265	 (11.7),	 245	 (31.9),	 243	 (100),	
191	(10.65),	196	(10.1),	164	(11.1),	140	(7.7),	127	(7.7),	113	
(8.8),	 77	 (10.9),	 63	 (26.4),	 51	 (41.4).	 Anal.	 calcd.	 for	 C16H16	
ClN3:	 C,	 67.25;	H,	 5.64;	N,	 14.70.	 Found:	 C,	 67.32;	H,	 5.70;	N,	
14.65	%.	
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Figure	1.	The	possible	mechanism	for	synthesis	of	2‐aminopyridines.
	
	
2‐Amino‐4‐(furan‐2‐yl)‐5‐isopropyl‐6‐methylnicotinonitrile	
(4e):	Color:	Grey	crystals.	Yield:	63%.	M.p.:	196‐198	°C.		FT‐IR	
(KBr,	 ν,	 cm‐1):	 3425,	 3319	 (NH2),	 2207	 (CN),	 1645	 (C=N).	 1H	
NMR	 (600	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 0.94	 (d,	 6H,	 J	 =	 6.6	 Hz,	
2CH3),	2.10	(septet,	1H,	J	=	6.6	Hz,	CH),	2.51	(s,	3H,	CH3),	5.73	
(br,	2H,	NH2),	6.59	(dd,	1H,	J	=	1.8	and	3.6	Hz,	H4‐furan),	7.40	
(d,	1H,	 J	=	3.6	Hz,	H3‐furan),	7.62(d,	1H,	 J	=	3.3	Hz,	H5‐furan).	
13C	NMR	(150	MHz,	DMSO‐d6,	δ,	ppm):	165.6	(C6),	160.6	(C2),	
148.7	(C4),	144.2	(C2'),	140.6	(C5'),	117.7	(C5),	112.7	(CN),	112.4	
(C3'),	 108.6	 (C4'),	 81.4	 (C4),	 47.7	 (C7),	 28.6	 (C8),	 22.4	 (2C,	 C9,	
C10).	MS	(EI,	m/z	(%)):	241	(M+,	13.1),	226	(16.4),	200	(19.0),	
199	 (100),	 185	 (4.4),	 129	 (10.0),	 127	 (12.9),	 103	 (10.7),	 91	
(12.8),	 77	 (16.4),	 63	 (26.5),	 51	 (24.3).	 Anal.	 calcd.	 for	
C14H15N3O:	C,	69.69;	H,	6.27;	N,	17.14.	Found:	C,	69.63;	H,	6.21;	
N,	17.10%.	
2‐Amino‐5‐isopropyl‐6‐methyl‐4‐(thiophen‐2‐yl)nicotine	
nitrile	 (4f):	 Color:	 Yellowish	white	 crystals.	 Yield:	 61%.	M.p.:	
185‐187	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3423,	3319	(NH2),	2202	(CN),	
1645	(C=N).	1H	NMR	(600	MHz,	DMSO‐d6,	δ,	ppm):	0.94	(d,	6H,	
J	=	6.6	Hz,	2CH3),	2.09	(septet,	1H,	J	=	6.6	Hz,	CH),	2.48	(s,	3H,	
CH3),	6.09	(br,	2H,	NH2),	7.18	(dd	 ,	1H,	J	=	1.2	and	4.2	Hz,	H4‐
thiophene),	 7.55	 (dd,	 1H,	 J	 =	 1.2	 and	 3.6	 Hz,	 H5‐thiophene),	
7.77	(dd,	1H,	J	=	1.2	and	3.6	Hz,	H3‐thiophene).	13C	NMR	(150	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 165.6	 (C6),	 160.6	 (C2),	 148.7	 (C4),	
144.2	 (C2'),	 140.6	 (C5'),	 117.7	 (C5),	 112.7	 (CN),	 112.4	 (C3'),	
108.6	(C4'),	81.4	(C4),	47.7	(C7),	28.6	(C8),	22.4	(2C,	C9,	C10).	MS	
(EI,	m/z	(%)):	259	(M++2,	0.3),	257	(M+,	33.8),	242	(12.7),	215	
(100)	 200	 (14.6),	 197	 (18.6),	 185	 (12.3),	 174	 (20.7),	 157	
(17.3),	108	(14.2),	91	(11.6),	77	(11.8),	63	(17.5).	Anal.	calcd.	
for	C14H15N3S:	C,	 65.34;	H,	5.87;	N,	 16.33.	Found:	C,	 65.28;	H,	
5.82;	N,	16.27%.	
	
2.2.2.	ABTS	Antioxidant	assay	[18]	
		
Antioxidant	 activity	 determinations	 were	 evaluated	 from	
the	 bleaching	 of	 ABTS	 derived	 radical	 cations.	 The	 radical	
cation	was	 derived	 from	 ABTS	 [2,2'‐azino‐bis	 (3‐ethyl	 benzo	
thiazoline‐6‐sulfonic	acid)]	was	prepared	by	reaction	of	ABTS	
(60	μL)	with	MnO2	(3	mL,	25	mg/mL)	in	5	mL	aqueous	buffer	
solution	(pH	=	7).	After	shaking	the	solution	for	a	few	minutes,	
it	was	centrifuged	and	filtered.	
The	 absorbance	 (A	 control)	 of	 the	 resulting	 green‐blue	
solution	 (ABTS	 radical	 solution)	 was	 recorded	 at	 λmax	 =	 734	
nm.	The	absorbance	(A	test)	was	measured	upon	the	addition	
of	 (20	 μL	 of	 1	 mg/mL)	 solution	 of	 the	 tested	 sample	 in	
spectroscopic	 grade	 MeOH:Buffer	 (1:1,	 v:v)	 to	 the	 ABTS	
solution.	 The	 decrease	 in	 the	 absorbance	 is	 expressed	 as	
%inhibition	which	calculated	from	the	Equation	(1).	
	
%	Inhibition=	[A	(control)	‐	A	(test)/	A	(control)]	×	100	 (1)	
	
Ascorbic	acid	(20	μL,	2	mM)	solution	was	used	as	standard	
antioxidant	 (positive	 control).	 Blank	 sample	 was	 run	 using	
solvent	without	ABTS	(Table	1).	
	
Table	1.	ABTS	Antioxidant	activity	assay	of	the	new	compounds.	
Compound	no Absorbance	of	samples		
(λ,	734	nm)	
%	Inhibition
4a	 0.416	 16.8	
4b 0.489 2.2	
4c 0.420 16.0 
4d 0.428 14.4	
4e 0.407 18.6	
4f 0.320 36.0	
Control	of	ABTS	a 0.500 0.0	
Ascorbic	acid 0.061 87.8	
a	 ABTS:	 The	 method	 used	 for	 antioxidant	 activity,	 (%)	 Inhibition	 =	 [A	
(control)	–	A	(test)	/A	(control)]	×	100.	
	
3.	Results	and	discussion		
	
3.1.	Chemistry	
	
Scheme	1	describes	 the	synthesis	of	 the	target	molecules.	
The	 target	 compounds	 2‐amino‐5‐isopropyl‐4‐(4‐aryl)‐6‐
methylnicotinonitrile	(4a‐f)	were	obtained	with	high	yield	and	
purity	 via	 one‐pot	 condensation	 of	 malononitrile	 (1),	 4‐
methylpentan‐2‐one	 (2),	 aryl	 carboxaldehyde	 (3a‐f)	 and	
ammonium	acetate	in	ethanol.	
The	 structure	 of	 compounds	4a‐f	was	 established	 by	 the	
spectral	 data.	Whereas,	 the	 IR	 spectra	 showed	 characteristic	
absorption	 bands	 within	 3426‐3315	 cm‐1,	 corresponding	 to	
amino	groups,	2212‐2202	cm‐1	due	to	cyano	groups	and	1651‐
1648	 cm‐1	 corresponding	 to	 C=N	 groups.	 Further,	 their	 1H	
NMR	 displayed	 singlet	 signal	 within	 δ	 2.52‐2.48	 ppm,	which	
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corresponding	to	three	proton	of	CH3,	doublet	signal	within	δ	
2.10‐2.09	ppm,	which	due	to	two	C9,10H3	groups,	septets	within	
δ	2.10‐2.09	ppm	due	 to	one	proton	of	C7H	groups	and	broad	
singlet	signal	corresponding	 to	 two	protons	of	amino	groups.	
The	 1H	 NMR	 of	 compound	 4b	 and	 4c	 exhibited	 two	 singlet	
signals	 at	 2.42	 and	 3.87	 ppm	 corresponding	 to	 methyl	 and	
methoxy	 protons,	 respectively.	 Moreover	 the	 13C	 NMR	 of	
compounds	4a‐f	displayed	signals	within	δ	165.6‐163.3,	160.7‐
160.2,	 153.8‐145.2,	 117.7‐117.0	 and	 87.1‐81.4	 ppm	 due	 to	
pyridine	 nucleus.	 Furthermore,	 the	 mass	 spectra	 of	
compounds	 4a‐f	 displayed	 the	 base	 beaks	 at	m/z	 208,	 222,	
238,	 242,	 198	 and	 214,	 respectively	 due	 to	 M+‐isopropyl	
moiety.	The	formation	of	compounds	4a‐f	can	be	explained	in	
the	 following	 possible	 mechanism	 Figure	 1.	 There	 are	 two	
routes	in	the	first	one:	the	ketone	(2)	reacted	with	ammonium	
acetate	 to	 form	the	enamine	derivative	 II	which	reacted	with	
the	 arylidene	 derivative	 III	 [which	 formed	 from	 reaction	 of	
aldehyde	3	and	malononitrile	(1)]	to	form	the	Micheal	adducts	
IV,	 the	 intermediate	 IV	 cyclized	 to	 dihydropyridine	 V	 then	
autoxidized	to	aminopyridine	4a‐f,	Figure	1.	
	
3.2.	ABTS	Antioxidant	assay	
	
The	newly	synthesized	compounds	were	screened	for	their	
antioxidant	 activity	 using	 2,2'‐azino‐bis‐(3‐ethylbenzothiazo	
line‐6‐sulfonic	acid)	(ABTS)	method	which	reported	by	Lissi	et	
al.	[18].	The	antioxidant	activity	assay	employed	here	is	one	of	
the	 several	 assays	 that	 depends	 on	 measuring	 the	
consumption	of	stable	free	radicals	i.e.	evaluate	the	free	radical	
scavenging	 activity	 of	 the	 investigated	 component.	 The	
methodology	assumes	that	the	consumption	of	the	stable	free	
radical	(X')	will	be	determined	by	reactions	as	followed:	
	
XH	+	Y'	→	X'	+	YH	 	 	 	 	 (2)	
	
Total	 antioxidant	 potential	 of	 resinous	 exudates	 from	
Heliotropium	species,	and	a	comparison	of	the	ABTS	methods.		
The	 rate	 and/or	 the	 extent	 of	 the	 process	 measured	 in	
terms	of	the	decrease	in	X'	concentration,	would	be	related	to	
the	ability	of	 the	added	compounds	 to	 trap	 free	 radicals.	The	
decrease	 in	 color	 intensity	of	 the	 free	 radical	 solution	due	 to	
scavenging	 of	 the	 free	 radical	 by	 the	 antioxidant	 material	 is	
measured	calorimetrically	at	a	specific	wavelength.	The	assay	
employs	the	radical	cation	derived	from	2,2'‐azino‐bis‐(3‐ethyl	
benzthiazoline‐6‐sulfonic	acid)	as	stable	free	radical	to	assess	
antioxidant	potential	of	the	investigated	compounds	[19,20].	
The	 results	 showed	 that	 compounds	4a‐f	displayed	weak	
antioxidant	 activities.	 By	 comparing	 the	 results	 obtained	 of	
antioxidant	 of	 the	 compounds	 reported	 in	 this	 study	 to	 their	
structures,	the	following	structure	activity	relationship	(SARs)	
were	postulated:		
i. Compound	 4e	 is	 more	 potent	 than	 compound	 4a	
which	may	be	due	to	replacement	of	phenyl	moiety	by	
furan,	
ii. Compound	 4e	 has	 activity	 less	 than	 compound	 4f	
which	 may	 be	 attributed	 to	 replacement	 of	 furan	
moiety	by	thiophene,	
iii. Compounds	 4b,	 4c	 and	 4d	 are	 less	 potent	 than	
compound	 4a	 due	 to	 presence	 of	 electron	 donating	
group.		
	
4.	Conclusion	
	
The	objective	of	 the	present	 study	was	 to	 synthesize	 and	
evaluate	 the	 antioxidant	 activity	 of	 some	 novel	 2‐amino	
pyridine	with	the	hope	of	discovering	new	structure	serving	as	
antioxidant	agent.	The	data	showed	clearly	that	all	compounds	
displayed	 weak	 in	 vitro	 antioxidant	 activities	 using	 ABTS	
method.		
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